Enforcement Report - Week of June 19, 2024
19 Jun 2024 //
FDA
Apotex`s Generic Mometasone Furoate Receives Approval in the U.S.
23 Apr 2024 //
FDA
Aurobindo receives USFDA approval for Mometasone Furoate Monohydrate nasal spray
20 Mar 2024 //
INDIANPHARMAPOST
Amneal`s Generic Mometasone Furoate Receives Approval in the U.S.
14 Jun 2023 //
FDA
Enforcement Report - Week of January 25, 2023
25 Jan 2023 //
FDA
Novartis` Atectura Breezhaler Receives Approval in Europe
08 Dec 2022 //
EMA
Health Canada approves Ryaltris for treatment of Seasonal Allergic Rhinitis
26 Sep 2022 //
EXPRESS PHARMA
Glenmark bets on respiratory drug, licensing deals to improve business
16 Sep 2022 //
ECONOMIC TIMES
Glenmark`s partner Hikma launches specialty drug Ryaltris in US
30 Aug 2022 //
ECONOMICTIMES
Hikma launches RYALTRIS seasonal allergic rhinitis nasal spray in the US
30 Aug 2022 //
PRNEWSWIRE
Enforcement Report - Week of July 13, 2022
13 Jul 2022 //
FDA
Glenmark launches FDC asthma medication in India
15 Jun 2022 //
ET HEALTH
Novartis to present new findings of Enerzair Breezhaler at ERS congress
06 Sep 2021 //
PHARMABIZ
Enforcement Report - Week of April 14, 2021
14 Apr 2021 //
FDA
Novartis Phase III IRIDIUM data in Lancet Respiratory Medicine show of Enerzair®
10 Jul 2020 //
PRESS RELEASE
Novartis Europharm Generic Bemrist (Indacaterol)Receives Approval in Europe
24 Jun 2020 //
EMA
Novartis’ asthma triple heads CHMP’s latest meeting
05 May 2020 //
PMLIVE
First triple combination therapy for asthma with optional electronic sensor
30 Apr 2020 //
EMA
Hikma & Glenmark Enter into Exclusive Licensing Agreement for Ryaltris™
27 Feb 2020 //
PR NEWSWIRE
Hikma Pharma to commercialise Glenmark Pharma’s new nasal spray Ryaltris in US
26 Feb 2020 //
PHARMABIZ
Glenmark gets approval from Australian regulator to commercialise Ryaltris
20 Dec 2019 //
BUSINESS STANDARD
With EMA review in progress, Novartis unveils more data on asthma therapy
06 Dec 2019 //
END PTS
EMA committee recommends approval of Bayer`s Neptra
15 Oct 2019 //
PHARMABIZ
Sosei Heptares Notes the Announcement of Results from Phase III IRIDIUM Study
02 Oct 2019 //
BUSINESSWIRE
HiFiBiO`s Kite-backed C round; Kyowa Kirin`s Parkinson`s nod; Relief for Sun
30 Aug 2019 //
FIERCE PHARMA
Enforcement Report - Week of August 14, 2019
14 Aug 2019 //
FDA
Glenmark has wind knocked out of NDA for respiratory drug by FDA
25 Jun 2019 //
FIERCE PHARMA
Novartis hits targets in late-stage QMF149 asthma trial
01 Jun 2019 //
PHARMATIMES
Investigational Novartis therapy smashes primary & secondary endpoints in asthma
31 May 2019 //
PHARMAFILE
Glenmark Pharma signs an agreement with Grandpharma
06 Feb 2019 //
BIOSPECTRUM ASIA
Glenmark in second licensing deal for anti-histamine
10 Jan 2019 //
PRESS RELEASE
Torrent Pharms Ltd’s Generic Mometasone Furoate Receives Approval in the US
21 Jul 2018 //
FDA
Glenmark Pharma inks pact with Seqirus
06 Jul 2018 //
HINDU BUSINESS LINE
Glenmark Announces the Company`s First New Drug Application for Ryaltris™
21 May 2018 //
PR NEWSWIRE
Five medicines recommended for approval, including two orphans
23 Feb 2018 //
EMA
Enforcement Report - Week of February 7, 2018
07 Feb 2018 //
FDA
Successful reclassification of Nasonex Allergy Control Nasal Spray
10 Jul 2017 //
GOVTUK
Amneal`s Generic Mometasone Furoate Receives Approval In US
28 Dec 2016 //
FDA
Maha FDA to launch massive crackdown against manufacturers of steroid creams
12 Dec 2016 //
PHARMABIZ
Allergy battle goes as GSK`s Flonase,Sanofi`s Nasacort roll out OTC sprays
05 Apr 2016 //
FIERCE PHARMA MARKETING
Novartis, GSK asthma meds linked to more side effects than Merck drugs
19 Nov 2015 //
FIERCE PHARMA
Despite Generic Erosion of Current Market, Asthma Market Will Remain Steady
22 Sep 2015 //
PR NEWS WIRE
FDA pulls fairness cream off market, more brands may face similar action
07 Sep 2015 //
MUMBAI MIRROR
Merck job-cutting tensions displayed in public emails from Frazier, union rep
19 Aug 2015 //
FIERCE PHARMA
Merck Canada Recalls Zenhale Aerosol due to the possibility of device malfunction
20 Jun 2015 //
HEALTHY CANADIANS